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Tumor cells can vary epigenetically during ionizing irradiation 
(IR) treatment. These epigenetic variegations can influence 
IR response and shape tumor aggressiveness. However, 
epigenetic disturbance of histones after IR, implicating in 
IR responsiveness, has been elusive. Here, we investigate 
whether altered histone modification after IR can influence 
radiation responsiveness. The oncogenic CXCL12 mRNA 
and protein were more highly expressed in residual 
cancer cells from a hepatoma heterotopic murine tumor 
microenvironment and coculture of human hepatoma Huh7 
and normal IMR90 cells after radiation. H3K4 methylation 
was also enriched and H3K9 methylation was decreased 
at its promoter region. Accordingly, invasiveness and the 
subpopulation of aggressive CD133+/CD24– cells increased 
after IR. Histone demethylase inhibitor IOX1 attenuated 
CXCL12 expression and the malignant subpopulation, 
suggesting that responses to IR can be partially mediated 
via histone modifications. Taken together, radiation-induced 
histone alterations at the CXCL12 promoter in hepatoma 
cells are linked to CXCL12 upregulation and increased 
aggressiveness in the tumor microenvironment.
Keywords: CXCL12, histone modification, malignancy, 
radiation, tumor microenvironment
INTRODUCTION
Radiation is one of the principal methods of cancer treat-
ment, but its effectiveness is often restricted by tumor re-
sistance and aggressiveness. Resistance and aggressiveness 
can be intrinsic to the tumor before radiation treatment 
or acquired during treatment. A defective DNA damage 
checkpoint is a common intrinsic factor related to radiation 
resistance which allows the cell to bypass DNA repair to con-
tinue growing and proliferating (Bao et al., 2006). Acquired 
resistance and aggressiveness can develop after receiving 
radiation treatment in tumors that were initially sensitive 
but adapt to become resistant and aggressive via mutations 
arising during treatment or various other responses such as 
altered expression of the therapeutic target and activation 
of alternative compensatory pathways. Moreover, tumors 
can have a wide spectrum of genetic and epigenetic het-
erogeneity, so radiation resistance and aggressiveness can 
arise through radiation-induced selection of small resistant 
subpopulations that become intensified. Tumors have many 
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adaptive responses to the continuously changing tumor mi-
croenvironment during radiation treatment. Most use quick 
and transient epigenetic mechanisms, but genetic processes 
can allow tumors to stably respond to radiation and survive.
 As our understanding of molecular signatures and geno-
types of radiation resistant tumors has advanced, the mech-
anisms of resistance to radiation learned from earlier studies 
help predict responsiveness to radiation treatment and elu-
cidate mechanisms of resistance to combinational radiation 
treatment with molecular targeted agents such as PARP in-
hibitors (Guillot et al., 2014). Nevertheless, tumors are often 
adaptable, and the inactivation of death pathways and the 
activation of survival pathways can lead to aggressiveness. 
Importantly, epigenetic changes and the influence of the 
local tumor microenvironment can contribute to malignancy. 
More recently, treatment failure was attributed to either a 
small subpopulation of malignant tumor cells or the presence 
of cancer stem cells (CSCs) and their increased population 
(Hong et al., 2016; Rich, 2007).
 The epigenetic approach in combination with genomic 
and proteomic techniques is more widely applied to iden-
tification of novel genes and signaling pathways that are 
involved in determining the responsiveness of tumors to a 
specific treatment. Moreover, epigenetic processes in tumors 
are critical mechanisms that regulate aspects of cancer cell 
biology including responsiveness. Epigenetic mechanisms 
regulate gene expression primarily through DNA methyla-
tion, histone modifications such as acetylation, methylation, 
phosphorylation, and ubiquitination, and miRNA. DNA 
hypo- and hyper-methylation at promoter regions can lead 
to transcriptional induction and repression, respectively. Sim-
ilarly, histone modifications can regulate gene transcription. 
For example, active promoters are marked with increased 
trimethylation of H3 at lysine 4 (H3K4me3) or acetylated H3 
at lysine 9 (H3K9ac), and inactive promoters are marked with 
increased trimethylated H3 at lysine 27 (H3K27me3) or lysine 
9 (H3K9me3) (Choi and Lee, 2013).
 Earlier epigenetic studies largely focusing on DNA methyl-
ation of tumors resulted in a substantial increase in our ability 
to identify genes that are important for the responsiveness 
of tumors to certain treatment settings and aggressiveness. 
Thus, there have been limited studies of the influence of ion-
izing radiation on histone modifications at particular genes 
and gene expression. To overcome malignancy and increase 
the effectiveness of radiation treatment, we analyzed histone 
modifications at the promoters of specific genes linked to 
responsiveness and malignancy, focusing on differential ex-
pression before and after ionizing radiation. For example, the 
CXCL12 (stromal cell-derived factor-1, SDF-1)-CXC receptor 
4/7 (CXCR4/7) axis, which plays a biologically relevant role in 
tumor progression, angiogenesis, metastasis, proliferation, 
and survival (Kryczek et al., 2007; Teicher and Fricker, 2010), 
is highly expressed in multiple cell types including hematopoi-
etic stem cells, lymphocytes, endothelial and epithelial cells, 
and cancer cells (Kryczek et al., 2007).
 Here, we found upregulation of CXCL12 and altered his-
tone modifications at its promoter regions in response to 
ionizing radiation in a hepatoma heterotopic murine tumor 
microenvironment and human xenograft and coculture sys-
tems. Our results reveal a close relationship between the his-
tone methylation profile at the promoter and expression of 
the CXCL12 gene. Notably, we indicate that the induced level 
of CXCL12 may contribute to acquired invasiveness and stem-
ness. Collectively, our results show that CXCL12 upregulation 
mediated by histone modification dynamics at the promoter 
in the residual hepatoma cells after radiation treatment may 
be at least partially responsible for the acquired adaptation to 
radiation and aggressiveness during treatment in tumor cells. 
Thus, epigenetic modulation can be a promising therapeutic 
option to refine radiation treatment.
MATERIALS AND METHODS
A murine in vivo heterotopic tumor model and radiation 
administration
A spontaneous murine hepatocarcinoma (HCa-I; generously 
provided by Luka Milas, University of Texas MD Anderson 
Cancer Center) was used in this study as a murine in vivo 
heterotopic tumor model. A heterotopic tumor model was 
generated in the right thigh of six-week-old male syngeneic 
C3H/HeN mice, and radiation was delivered as described in 
our previous study (Lee et al., 2016). Briefly, 1 × 106 HCa-I 
cells were injected into the right thigh muscles of mice. 
Two weeks after implantation, three mice were randomly 
assigned to a radiation treatment group or a control group. 
Radiation was administered to the implanted tumor as a 
single dose of 10 Gy with 320 kV X-ray using the X-RAD 320 
(Precision X-ray, USA). Irradiated and non-irradiated tumor 
samples were obtained 1 or 3 days after radiation. All animal 
experiments were performed in accordance with the Animal 
Research Committee’s Guidelines at Yonsei University Medical 
College, and all facilities were approved by the Association 
for Assessment and Accreditation of Laboratory Animal Care 
(IACUC-2012-0177).
Establishment of human hepatoma xenograft, coculture 
models, radiation, and treatment with DNA damaging 
agents
The human hepatocarcinoma cell line Huh7, normal lung fi-
broblast cell line IMR90, and WI38 cells (purchased from the 
American Type Culture Collection) were cultured in DMEM 
(Welgene, Korea) supplemented with 10% fetal bovine 
serum (FBS; HyClone, USA) and 1% penicillin/streptomycin 
(Gibco, USA). Subcutaneous xenotransplantation of hepato-
ma Huh7 cells (1 × 107 cells) into Balb/c nude mice were gen-
erated. The implanted tumor was locally exposed to radiation 
of 5 Gy. To co-culture two cell lines, 1 × 105 Huh7 cells were 
cultured in a transmembrane insert (0.3 mm pore; SPL, Korea) 
for 6 h and the insert was translocated into a well in a 6-well 
plate where IMR90 cells were cultured until approximately 
90% confluent. They grew for another 24 h in the presence 
of histone demethylase inhibitor (5 mM IOX-1 or 10 mM 
GSK-J1), histone methyltransferase inhibitor (0.5 mM chaeto-
cin), histone deacetylase inhibitor (0.1 mM TSA), or their vehi-
cles. Huh7 cells were irradiated with a dose of 5 or 10 Gy. For 
three-dimensional (3D) culture, the grown Huh-7 cells were 
detached from culture plates using AccumaxTM (Millipore, 
USA) DPBS and approximately 1 × 106 cells were seeded on a 
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35 mm-culture dish coated with hydrophilic polymer (Prime-
Surface; Akita Sumitomo Bakelite, Japan). Spheroids formed 
after 24 h before being irradiated. For induction DNA dam-
age, Huh7 cells were treated with 50 mM etoposide (Sigma, 
USA) or 50 mM phleomycin (Sigma) for 2 h.
RNA isolation and RT-PCR/qRT-PCR
Total RNA was isolated from tumor tissue and normal peri-
tumor liver tissue cells obtained from the heterotopic tumor 
model and cultured Huh7 cells using RNeasy Mini Kit (Qia-
gen, USA) according to the manufacturer’s instructions. Re-
verse transcription polymerase chain reaction (RT-PCR) was 
carried out using 2 µg of total RNA. Quantitative real-time 
PCR (qRT-PCR) was performed using Maxima SYBR Green 
(Thermo Scientific, USA) with Rotor Gene Q (Qiagen). The 
primers used for qRT-PCR are listed in Supplementary Tables 
S1 and S2.
Quantitation of CXCL12 proteins using ELISA
The amount of CXCL12 proteins were measured using ELISA 
(R&D System, USA) according to manufacturer’s protocol.
Chromatin immunoprecipitation
Chromatin immunoprecipitation was carried out using EZ-
ChIP Kit according to manufacturer’s protocols (Millipore) 
with antibodies against H3K4me3, H3K9ac, H3K9me3, or 
without antibody (input). The immunoprecipitated and input 
DNAs were analyzed using qPCR. The primer sequences are 
described in Supplementary Table S2.
Immunoblotting
Cell lysates in RIPA buffer (50 mM Tris-Hcl pH 7.5, 150 mM 
NaCl, 1% NP-40, 0.1% SDS, protease inhibitor) were immu-
noblotted using anti-CCAAT/enhancer-binding protein β (c/
EBPβ) antibody (Abcam, UK). Immunoreactive bands were 
normalized to the control anti-actin (Santa Cruz Biotechnolo-
gy, USA) band.
Invasion assay
Matrigel invasion chambers (24 well and 8 mm pore; BD Bio-
sciences, USA) were used for the invasion assay. 0.5 ml of 
cell suspensions in culture medium containing 5 × 104 cells/
ml were added to each 24 well invasion chamber. Either me-
dium or medium supplemented with the indicated dose of 
recombinant CXCL12 (Thermo Fisher Scientific) was added 
to the lower chamber. Chambers were incubated overnight 
in a humidified incubator at 37°C and 5% CO2. Non-invading 
cells on the top of the Matrigel matrix in the upper chamber 
were removed twice using a cotton swab (Sun et al., 2018). 
The cells on the lower surface of the membrane were stained 
with hematoxylin-eosin for 5 min and the invaded cells were 
counted under the microscope in several fields in triplicate 
(Carl Zeiss, USA). Data was expressed as the percent invasion 
through the Matrigel matrix and membrane relative to the 
migration of cells through the uncoated membrane.
C/EBPβ and CXCL12 knockdown and transfection
Double-stranded short hairpin RNA for c/EBPβ was generat-
ed using the pSUPER.retro.puro vector (Oligoengine, USA). 
The siRNA primers were designed to target c/EBPβ (open 
reading frame, 5′-CCAAGAAGACCGTGGACAA-3′; 3′-UTR, 5′
-GAAGAAACGTCTATGTGTA-3′) and CXCL12 (5′-UTR, 5′-CCAT-
GAACGCCAAGGTCGT-3′). Transfections were performed 
using an Effectene kit (Qiagen) for knock-down in mammali-
an cells.
Flow cytometry analysis of CD133+/CD24– expression
Expression of CD133 and CD24 in Huh7 cells was determined 
using flow cytometry at 3 day after γ-irradiation. After stain-
ing with anti-CD133-FITC and CD24-PE antibodies (Miltenyi 
Biotec, Germany), the cells were analyzed using flow cytom-
etry (BD FACSAria III; BD Biosciences). Data are shown as the 
mean ± SD (n = 3).
Statistical analysis
All experimental data were obtained in at least triplicate un-
less otherwise mentioned and are presented as mean ± stan-
dard deviation. Statistical comparison by analysis of variance 
was performed at a significance level of P < 0.05 based on 
the ANOVA t-test and Student’s t-test.
RESULTS
Transcriptional response to radiation in tumor microenvi-
ronment models
Both the in vivo murine heterotopic tumor microenvironment 
model (Lee et al., 2016) and human xenograft tumor model 
and in vitro coculture system were established to investigate 
responses to radiation. To analyze the expression of genes, 
which plays a biologically relevant role in tumor progression, 
angiogenesis, metastasis, proliferation and survival (Kryczek 
et al., 2007; Teicher and Fricker, 2010), in murine tumor mi-
croenvironment in response to radiation, we used transplant-
able murine tumor HCa-I cells that are highly radioresistant 
with a radiation dose yielding a 50% tumor cure rate above 
80 Gy (Lee et al., 2016). Expression of the CXCL12-CXCR4/7 
axis that is highly expressed in multiple cell types including 
hematopoietic stem cells and cancer cells (Kryczek et al., 
2007), and contributes to tumor growth and spread (Chat-
terjee et al., 2014; Domanska et al., 2013), were compared 
before and after γ-irradiation, using HCa-1 cells in a hetero-
topic tumor model. Higher expression of CXCL12-CXCR4/7 
was observed in surviving HCa-1 cells in the murine hetero-
topic tumor microenvironment after γ-irradiation than in the 
untreated HCa-1 cells (Fig. 1A). The expression of CXCL12 
was prominently increased in surviving HCa-1 cells by approx-
imately 17-fold 72 h after irradiation, and mRNA expression 
levels of its receptor CXCR4/7 increased by approximately 
two-fold 72 h after irradiation (Fig. 1A), suggesting that ra-
diation induces expression of the CXCL12-CXCR4/7 axis in 
the tumor microenvironment. Vimentin, encoded by the VIM 
gene and a marker of mesenchymal cells or cells undergoing 
an epithelial-to-mesenchymal transition during metastatic 
progression, and another oncogenic MTA1 gene were ap-
proximately 3-fold higher, while expression of c-myc, CDH1, 
and CCND1 and other genes varied little compared to the 
levels in HCa-1 cells from an untreated heterotopic tumor 
microenvironment (Supplementary Fig. S1). Thus, these ex-
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pression data in the heterotopic tumor microenvironment in-
dicate that expression of some but not most genes in cancer 
cells are affected by irradiation.
 To compare the transcriptional responses to radiation in 
the murine and human tumor microenvironment models, the 
human tumor xenograft model, and the co-culture system in 
a plate with insets were used. Human hepatoma Huh7 cells 
were transplanted into immunocompromised mice or co-cul-
tured with normal IMR90 cells in insets. In the human hepa-
toma xenograft model, radiation apparently induced CXCL12 
expression 5.2-fold and slightly induced expression of 
CXCR4/7 1.2-fold 5 days after radiation compared with that 
in untreated cells (Fig. 1B). Consistent with radiation-induced 
CXCL12 expression in the xenograft model, the expression of 
CXCL12 in the cocultured hepatocarcinoma Huh7 cells 3 days 
after γ-irradiation increased approximately 5-fold compared 
with the level before irradiation (Fig. 1C). In a similar man-
ner, irradiation enhanced the levels of CXCR4/7 transcripts 
in Huh7 cells approximately 3.3- and 2.3-fold, respectively, 
5 days after radiation (Fig. 1C). Along with the CXCL12-CX-
CR4/7 transcriptional data obtained from the murine hetero-
topic hepatoma model, the transcriptional expression of the 
CXCL12-CXCR4/7 axis was induced in response to radiation 
in the human hepatoma in vivo xenograft model and in vitro 
Fig. 1. Radiation induces altered transcription in an in vivo murine heterotopic tumor microenvironment (A), a human hepatoma 
xenograft (B), and coculture system (C-E). (A) Transcript levels of CXCL12-CXCR4/7 axis genes were elevated in the heterotopic tumor 
model after radiation. mRNA levels of CXCL12-CXCR4/7 genes were measured approximately 1 or 3 days after exposure to radiation. The 
mRNA level of the control sample without radiation was arbitrarily set to one. (B) In the human hepatoma xenograft model, radiation enhanced 
the CXCL12-CXCR4/7 genes. After irradiation, the mRNA levels were measured 3 to 5 days later in the xenografted Huh7 cells. The levels of 
the unirradiated samples were arbitrarily set to one. (C) Expression of CXCL12-CXCR4/7 pathway genes increased 3 to 5 days after radiation 
in human hepatoma Huh7 cells cocultured with IMR90 cells. (D) The coculture (Huh7 + IMR90) effect on the radiation-induced CXCL12 
expression was analyzed compared to the single-cultured Huh7 cells. Huh7 cells were grown in single- (Huh7 only) or coculture with IMR90 
cells (Huh7 + IMR90) and exposed to radiation (IR) or not. The CXCL12 mRNA levels in the unirradiated single- or cocultured Huh7 cells were 
set to one. (E) The radiation or coculture-induced CXCL12 proteins were evaluated using ELISA. *P < 0.05, **P < 0.01, ***P < 0.001.
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coculture model.
 Interestingly, CXCL12 mRNA induction by radiation in the 
cocultured Huh7 cells appeared to be larger than in the sin-
gle cultured Huh7 cells (Fig. 1D), indicating that coculture of 
cancer and normal cells, mimicking tumor microenvironment, 
affects CXCL12 expression, presumably having benefits for 
tumor cells. In parallel with the CXCL12 mRNA data, the 
amounts of CXCL12 protein also increased in the cocultured 
hepatoma Huh7 cells after γ-irradiation (Fig. 1E). The level 
of CXCL12 protein was elevated in Huh7 cells cocultured 
with normal cells without γ-irradiation (approximately 7.4-
fold) compared to the single-cultured Huh7 cells. This level 
was comparable to the single-cultured and irradiated Huh7 
cells (Fig. 1E). Also, radiation further increased the CXCL12 
Fig. 2. Epigenetic modifications in response to radiation at the CXCL12 promoter in the murine heterotopic hepatoma micro environment (A), 
human he patoma xenograft (B), and co culture (C and D) models. The levels of the unirradiated samples were arbitrarily set to one. (A) 
At the murine CXCL12 promoter, alterations in trimethylation at histone 3 lysine 4 (H3K4me3) and lysine 9 (H3K9me3) were monitored 1 
to 3 days after ra diation. (B) Modifications of H3K4me3, H3K9me3, and ace tylation at histone 3 lysine 9 residue (H3K9ac) at the human 
CXCL12 promoter were evaluated 1 to 3 days after radiation in the xenografted Huh7 cells. (C and D) The experiment in (B) was repeated 
in single-cultured (C) and cocultured (D) Huh7 cells with or without radiation. Huh7 cells were cultured alone (C; Huh7) or together 
with IMR90 cells (D; Huh7 co-cultured with IMR90) and treated with or without γ-irradiation. CXCL12 mRNA levels were analyzed 3 or 5 
days after irradiation. (E) Huh7 cells were treated with etoposide or phleomycin for 2 h. Three days after treatment with DNA damaging 
agents, CXCL12 mRNA levels were analyzed and modifications of H3K4me3 and H3K9me3 at the human CXCL12 promoter were 
evaluated. (F) Huh7 cells were pretreated with 10 mM ATM inhibitor (KU 55933; Sigma) for 30 min, followed by irradiation, CXCL12 
mRNA levels were monitored. Modifications in H3K4me3 and H3K9me3 at the human CXCL12 promoter were measured. *P < 0.05, **P 
< 0.01, ***P < 0.001.
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proteins approximately 2.1-fold in the cocultured Huh7 cells 
compared to the cocultured Huh7 cells without radiation or 
the single-cultured and irradiated Huh7 cells (Fig. 1E). Based 
on the radiation-induced CXCL12-CXCR4/7 expression in the 
murine tumor microenvironment model, the human hepa-
toma xenograft and coculture models showed that tumor 
microenvironmental conditions or radiation significantly in-
creases CXCL12-CXCR4/7 expression.
Epigenetic histone modifications at the CXCL12 promoter 
in response to radiation in tumor microenvironment models
Since the CXCL12-CXCR4/7 pathway is a crucial axis in car-
cinogenesis and angiogenesis linked to tumor progression 
(Domanska et al., 2013) and metastasis (Chatterjee et al., 
2014), we investigated molecular mechanisms leading to a 
radiation-induced increase in CXCL12 transcription. First, we 
tested whether histone modification at its promoter could 
cause the differential expression of the CXCL12 gene follow-
ing irradiation. We did this because histone modifications can 
generally alter gene expression, and histone hypoacetylation 
has been also reported to contribute to its downregulation 
(Romain et al., 2017). Thus, modifications at lysine 4 (H3K4) 
and lysine 9 (H3K9) residues in histone 3 (H3), which are im-
portant determinants of transcriptional activity in the CXCL12 
promoter, were analyzed using chromatin immunoprecipita-
tion with antibodies against specific H3 modifications in hep-
atoma cells in the murine and human in vivo/in vitro tumor 
microenvironments with or without γ-irradiation.
 The histone modifications in response to radiation were 
analyzed at murine and human CXCL12 promoters spanning 
–2 kb to +1 kb (Supplementary Fig. S2). At five sites within 
the promoter of murine CXCL12 (–2000 to –1650, –1700 
to –1440, –1160 to –810, –530 to –180, and –320 to +20 
bps from its transcription start site) in surviving HCa-1 cells 
after radiotherapy, increased histone tri-methylation at H3K4 
(H3K4me3) related to open chromatin mark was observed 
3 days after irradiation, but radiation had few effects at the 
other eight regions (Fig. 2A and Supplementary Fig. S3A). 
Another histone modification mark for transcriptional activa-
tion, acetylation at H3K9 (H3K9ac) increased at two regions 
(–530 to –180 and –110 to +240) but were little changed at 
the other regions after irradiation (Fig. 2A and Supplementa-
ry Fig. S3B), indicating that H3K9ac increments at the murine 
CXCL12 promoter are likely to be related to the radiation-in-
duced CXCL12 transcription in the murine tumor microenvi-
ronment (Fig. 1A). Also, the transcriptional repressive maker 
tri-methylation at H3K9 (H3K9me3) decreased at three 
regions (–1160 to –810, –530 to –180, and –110 to +200); 
however, no major changes were observed after radiation at 
the other regions of the CXCL12 promoter in the Hca-1 cells 
of tumor microenvironment (Fig. 2A and Supplementary Fig. 
S3C). These results indicate that decreased H3K9me3 is relat-
ed to radiation-induced CXCL12 transcription. Taken together 
with all tested histone modifications in response to radiation, 
the radiation-induced histone modification profile at the mu-
rine CXCL12 promoter in the tumor microenvironment (Fig. 
Fig. 2. Continued.
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2A and Supplementary Fig. S3) appeared to be correlated 
with CXCL12 upregulation in HCa-1 cells surviving irradiation 
(Fig. 1A).
 Next, we examined histone modifications at the CXCL12 
promoter after radiation in the human tumor microenviron-
ment-mimicking systems. Like the irradiated human tumor 
microenvironment, higher H3K4me3 modification was de-
tected at two sites (–1160 to –810 and –530 to –180 from its 
transcription start site) in the human promoter regions of the 
CXCL12 gene in xenografted Huh7 cells 3 days after irradi-
ation compared to control cells (Fig. 2B and Supplementary 
Fig. S4A). Also, the transcriptional repressive chromatin mark 
H3K9me3 was decreased at the sites after irradiation (Fig. 2B 
and Supplementary Fig. S4B). The increased H3K4me and 
decreased H3K9me modifications induced by radiation at the 
CXCL12 promoter in the xenografted Huh7 cells match with 
active promoters (Choi and Lee, 2013), suggesting that radi-
ation-induced histone modifications at the CXCL12 promoter 
region may contribute to CXCL12 upregulation.
 In further mechanistic studies on human hepatoma Huh7 
cells, we decided to focus on the upstream site (–530 to 
–180) (Figs. 2C and 2D). Consistent with the H3 modifica-
tions at the CXCL12 promoter in the irradiated-Huh7 cells 
of the xenograft model, H3K4me increased and H3K9me 
decreased at the same CXCL12 promoter site in irradiated 
Huh7 cells compared to cells before irradiation (Fig. 2C). Be-
cause coculture without irradiation could enhance CXCL12 
transcription and radiation-induced CXCL12 transcription 
was likely to be more strongly affected in the coculture, we 
compared histone modification levels in the coculture to the 
single-culture (Fig. 2D), in order to see coculture effects on 
the irradiation-induced histone modifications. The H3K4me3 
level at the CXCL12 promoter region in the irradiated single 
cultured cells increased approximately two-fold 3-days after 
irradiation. Similarly, radiation induced a H3K4me3 increase 
at the CXCL12 promoter by approximately two-fold after 
5 days in the cocultured Huh7 cells. Taken together with 
H3K4me3 modification data, it was suggested that the radia-
Fig. 3. The transcriptional factor c/EBPβ is required for radiation-induced CXCL12 expression. (A) Radiation induces c/EBPβ recruitment 
to the CXCL12 promoter in both single- or cocultured Huh7 cells. ChIP assays were carried out using anti-c/EBPβ antibody 1 to 5 days 
after treating Huh7 cells with or without γ-irradiation. The pulled-down chromatin pools were PCR amplified with primers targeting the 
CXCL12 promoter. The pulled-down chromatin samples immediately before radiation (0 day) were arbitrarily set to one. (B) The c/EBPβ 
knockdown levels were confirmed using western blotting. (C) The c/EBPβ knockdown alleviated radiation-induced CXCL12 expression. 
Time course analysis of CXCL12 mRNA levels were performed following radiation in Huh7 cells transfected with an empty (mock) or 
c/EBPβ silencing (sic/EBPβ) vectors one day earlier. The CXCL12 mRNA levels in non-transfected and non-irradiated Huh7 cells were 
arbitrarily set to one. *P < 0.05, **P < 0.01, ***P < 0.001.
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tion-induced H3K4me3 modification at the CXCL12 promot-
er may mediate radiation-induced CXCL12 expression.
 Because radiation therapeutics generally rely on the DNA 
damage response, we tested whether the transcriptional 
induction of CXCL12 and epigenetic changes at its promot-
er might occur in response to other DNA damaging agents 
like after radiation. Etoposide and phleomycin could induce 
CXCL12 transcription with increased H3K4me3 and reduced 
H3K9me3 at the promoter (Fig. 2E), which is analogous to 
what is induced by radiation. This suggests that DNA damage 
responses like the ATM/ATR-mediated DNA damage signaling 
pathway is implicated in radiation-induced CXCL12 transcrip-
tion concordant with its epigenetic changes. Thus, we ex-
amined if an ATM inhibitor could decrease radiation-induced 
CXCL12 transcription and alleviate the enriched H3K4me3 
and reduced H3K9me3 at its promoter. The radiation-in-
duced CXCL12 transcriptional induction and the H3K4me3 
enrichment/H3K9me3 reduction at the CXCL12 promoter re-
gion were reversed by the ATM inhibitor KU55933 (Fig. 2F). 
This supports the conclusion that radiation-induced CXCL12 
effects take place in a DNA damage-dependent manner.
Recruitment of transcriptional activator c/EBPβ  at the 
CXCL12 promoter is accompanied by epigenetic histone 
modification in response to radiation
Since c/EBPβ is known to regulate CXCL12 expression (Fu 
et al., 2014) and c/EBPβ is associated with a wide range of 
neoplastic disorders (Zahnow, 2011), we decided to investi-
gate engagement of c/EBPβ in the upregulation of CXCL12 in 
response to irradiation. We analyzed the c/EBPβ occupancy at 
the promoter following radiation. Recruitment of c/EBPβ was 
induced in the single- or cocultured Huh7 cells up to 5-days 
after irradiation, suggesting that changes in transcription 
factor occupancy are accompanied by epigenetic changes at 
the CXCL12 promoter in response to irradiation. Coculture 
and concomitant radiation induced its significant recruitment 
(approximately 2.4-fold) (Fig. 3A), further suggesting that c/
EBPβ may mediate radiation-induced CXCL12 transcription.
 To further confirm the involvement of c/EBPβ in radia-
tion-induced CXCL12 expression, we monitored CXCL12 
expression after radiation in the c/EBPβ knockdown cells 
(Figs. 3B and 3C, Supplementary Fig. S5). c/EBPβ knockdown 
ameliorated the radiation-induced CXCL12 expression (Fig. 
3C), indicating that c/EBPβ is required for radiation-induced 
CXCL12 upregulation.
 Based on the epigenetic data from murine and human tu-
mor microenvironment models, we concluded that radiation 
induces changes in histone modifications and transcription 
factor occupancy at specific sites in the CXCL12 promoter in 
the hepatoma tumor microenvironment, possibly leading to 
upregulation.
Enhanced CXCL12-CXCR4 loop in response to radiation
Because CXCR4/7, the receptors of CXCL12, were also en-
hanced by approximately two-fold 3 days after irradiation 
in an in vivo tumor microenvironment model (Fig. 1A), we 
examined whether increased CXCL12 after radiation could 
act on the tumor cells within the tumor microenvironment 
in a positive feedback loop. To do this, we monitored the 
effects after adding recombinant CXCL12 ligand (rCXCL12) 
and a chemokine receptor antagonist for CXCR4 and CX-
CL12-mediated chemotaxis, plerixafor octahydrochloride 
(AMD3100 8HCL) on CXCL12 mRNA expression and histone 
modifications at the promoter during a time course. Addition 
of rCXCL12 induced CXCL12 mRNA production (Fig. 4A) 
and higher ratio of H3K4me3 to H3K9me3 in the single- 
or co-cultured Huh7 cells (Fig. 4B) compared to untreated 
cells. In single- or cocultured Huh7 cells exposed to rCXCL12, 
CXCL12 mRNA increased up to two- and four-times, and the 
ratio of H3K4me3 to H3K9me3 increased up to four- and 
ten-times, respectively, compared to untreated control cells 
(Figs. 4A and 4B). The data from rCXCL12 experiments show 
correlation between CXCL12 mRNA expression and histone 
modification at the promoter. Also, the CXCR4 antagonist 
AMD3100 abrogated the rCXCL12 effects on CXCL12 mRNA 
expression and histone modifications in both single- and 
cocultured Huh7 cells (Fig. 4A). However, unlike the modu-
lation of CXCL12 expression, CXCR4/7 expression was only 
hardly or slightly modulated by rCXCL12 and CXCR4 antag-
onist 3 days after γ-irradiation (Figs. 4C and 4D). On the fifth 
day after γ-irradiation, rCXCL12 modestly enhanced CXCR4 
expression, but AMD3100 reversed the rCXCL12-induced 
CXCR4 expression in single and cocultured Huh7 cells (Fig. 
4C). In contrast, CXCR7 expression changed litter after the 
rCXCL12 and the CXCR4 antagonist (Fig. 4D). These results 
suggest that the radiation-induced CXCL12 increase can act 
as an autocrine signal, leading to reinforcing a positive CX-
CL12-CXCR4 circuit.
Radiation-induced CXCL12-CXCR4/7 expression contrib-
utes to tumor malignancy in surviving cells
We investigated the physiological changes in hepatoma cells 
with respect to changes in CXCL12-CXCR4/7 expression 
in the tumor microenvironment after radiation. The CX-
CL12-CXCR4/7 axis plays a variety of roles in tumor progres-
sion and malignancy including invasion (Domanska et al., 
2013). Thus, we studied the relationship between the radia-
tion-induced CXCL12-CXCR4/7 axis and invasion. To do this, 
we measured invasiveness of Huh7 cells with or without ra-
diation. Higher invasion was observed in the irradiated single 
cultured Huh7 cells compared to non-radiated cells (Fig. 5A). 
In a similar manner, radiation induced invasion of cocultured 
Huh7 cells compared to unirradiated control cells (Fig. 5A). 
Interestingly, invasion was enhanced in the cocultured Huh7 
cells without radiation compared to single cultured Huh7 
cells, indicating that the tumor microenvironment enables 
cancer cells to gain invasive and metastatic properties.
 To examine whether radiation-induced CXCL12 expression 
can mediate this radiation-induced invasion, invasiveness 
was monitored after treatment with recombinant CXCL12 
(rCXCL12) without radiation (Figs. 5B and 5C). Interesting-
ly, rCXCL12 addition without radiation induced invasion in 
both single- and cocultured Huh7 cells in a dose-dependent 
manner. Together with the radiation-induced invasion results, 
this correlation between rCXCL12 and invasion data indicate 
that radiation-induced CXCL12 can promote invasion of tu-
mor cells after radiation. To see whether radiation-induced 
CXCL12 plays a role in the invasion of radiation-treated tu-
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mor cells, we evaluated the invasiveness of CXCL12-deficient 
hepatoma cells after irradiation. CXCL12 knockdown alleviat-
ed the radiation-enhanced invasion (Fig. 4E), indicating that 
the radiation or DNA damaging agent (phleomycin)-induced 
CXCL12 contributes to malignancy of radiation-treated can-
cer cells.
 Because ECM proteins are required for invasion, we next 
investigated radiation effects on the invasive and metastat-
ic ECM proteins. MMP2/9 expression was compared to 
non-irradiated control cells. Coculture of Huh7 cells with 
normal cells slightly induced MMP2/9 proteins (about 40%) 
compared to the single culture. Radiation further intensified 
Fig. 4. Modulation of CXCL12 transcription by recombinant CXCL12 (rCXCL12) or a CXCR4 inhibitor AMD3100. (A) Recombinant 
CXCL12 (rCXCL12) induces expression of CXCL12, but AMD3100 inhibits the rCXCL12-induced CXCL12 expression in the single- (Huh7) 
and cocultured (Huh7 + IMR90) Huh7 cells. Huh7 cells were cultured alone (Huh7) or together with IMR90 cells (Huh7 + IMR90) and 
treated with rCXCL12 or AMD3100 for 24 to 72 h as described. CXCL12 mRNA levels were analyzed. (B) Modifications of H3 at CXCL12 
promoters by rCXCL12 or AMD3100 were analyzed in Huh7 cells for 24 to 72 h after treatment with rCXCL12 or AMD3100. ChIP assays 
were performed using anti-H3K4me and H3K9me antibodies. (C and D) The experiments in (A) were repeated for CXCR4 (C) and CXCR7 
expression (D). *P < 0.05, **P < 0.01, ***P < 0.001. (E) Huh7 cells transfected with an empty (mock) or CXCL12 silencing (shCXCL12) 
vectors one day earlier then irradiation or phleomycin treatment. Scale bar = 100 mm. Invasion was evaluated 3 days after irradiation or 
phleomycin treatment by incubating Huh7 cells on a Matrigel-coated chamber.
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MMP2/9 expression in the cocultured Huh7 cells by approxi-
mately 2.6- and 2.8-fold, respectively, 5-days after irradiation 
compared to cocultured and non-irradiated cells (Fig. 5D). 
Together, these data show that treatment with γ-irradiation 
results in increased expression of MMP2/9 and CXCL12-CX-
CR4/7 genes in human hepatoma microenvironments.
 To finally investigated whether radiation-induced MMP2/9 
expression was mediated by CXCL12. MMP2/9 expression 
was monitored after rCXCL12 or antagonist treatment with-
out radiation. Coculture of Huh7 cells mimicking the tumor 
microenvironment with rCXCL 12 treatment enhanced the 
expression of MMP2/9 genes (Fig. 5E). However, AMD 3100, 
an antagonist of the CXCL12-CXCR4/7 axis, abrogated the 
coculture- or rCXC12-mediated upregulation of MMP2/9 
genes (Fig. 5E). These data indicate that the radiation-in-
duced upregulation of CXCL12/CXCR4/7 axis can mediate 
upregulation of MMP2/9 genes and invasion.
Epigenetic inhibitor can undermine malignant cancer sub-
population expressing CSC markers, in conjunction with 
attenuation of the radiation-induced CXCL12 expression
Activation of the CXCL12-CXCR4/7 pathway promotes 
metastasis (Kryczek et al., 2007) and survival of cancer cells 
(Teicher and Fricker, 2010; Uy et al., 2012) and is involved in 
stemness (Würth et al., 2014) and drug resistance (Jung et 
al., 2013), resulting in gaining CSC properties (Domanska et 
al., 2013; Trautmann et al., 2014; Würth et al., 2014). Also, 
CXCR4 was identified as a prognostic marker for radiation 
resistant CSCs (Trautmann et al., 2014). Thus, we investi-
gated whether the radiation-induced CXCL12-CXCR4/7 
pathway affects the expression of the CSC markers CD133+/
CD24
–
 (Choi and Lee, 2013) in a population of Huh7 cells 
Fig. 5. Radiation or coculture increased invasiveness of Huh7 cells. (A) Invasion was evaluated by incubating Huh7 cells on a Matrigel-
coated chamber at the indicated times after coculture or irradiation. (B and C) rCXCL12 treatment induced invasion of Huh7 cells. 
Scale bar = 100 mm. (D) Expression of MMP-2 and -9 in Huh7 cells was induced by radiation or coculture. MMP-2 and -9 mRNA were 
measured at indicated times. The levels of MMP-2 and -9 mRNAs in the single-cultured and unirradiated Huh7 cells were arbitrarily set 
to one. (E) rCXCL12 induced MMP-2 and -9 expression like irradiation. In contrast, AMD3100 blocked rCXCL12-induced MMP-2 and -9 
expression. The MMP-2 and -9 mRNA levels at indicated times were measured after treatment with rCXCL12 with or without AMD3100. 
*P < 0.05, **P < 0.01.
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after irradiation. The Huh7 cells have a very small population 
expressing CSC markers for CD133+/CD24
– cells (Fig. 6). Radi-
ation affected the expression of these markers and changed 
the possibly malignant subpopulation by approximately 2.3 
to 3.8-fold in the irradiated Huh7 cells (Fig. 6A). Moreover, 
the CSC marker-expressing subpopulation increased more 
strongly to approximately 3.68-fold in the cocultured Huh7 
cells with normal IMR80 cells (comparable to 3.8-fold in the 
irradiated single cultured cell population) (Fig. 6A), suggest-
ing that the tumor microenvironment is important for the 
proportion of cell subpopulation expressing CSC markers. In 
the coculture system, radiation had a further impact on the 
expression of these markers in the Huh7 cells up to 6.8 to 
9.9-fold, further supporting the importance of the tumor mi-
croenvironment in expressing CSC markers.
 Next, we tested radiation effects on the subpopulation 
expressing CSC markers in tumor microenvironment using 
3D Huh7 culture (Fig. 6B). In a similar manner, radiation in-
creased the CSC subpopulation up to approximately 2.3-fold 
in 3D culture of Huh7 cells (Fig. 6B). The increase in the sub-
population displaying CSC markers in the 3D culture system 
after radiation indicates that surviving cancer cells after radio-
therapy can exhibit a malignant phenotype.
 Since radiation induced expression of the CXCL12-CX-
CR4/7 pathway along with epigenetic histone modification 
changes at the CXCL12 promoter in the tumor microenvi-
ronment, we tested whether and which epigenetic inhibitors 
could abrogate the radiation-induced CXCL12 expression. 
Next, we investigated whether this abrogative epigenetic 
inhibitor could diminish the subpopulation of CSC mark-
er-expressing cancer cells after radiation. First, we used two 
histone demethylase inhibitors (GSK-J1, a highly potent 
Jumonji H3K27 histone demethylase inhibitor, and IOX1, 
a broad spectrum inhibitor of 2-oxoglutarate oxygenases 
including JmjC demethylase), a histone methyltransferase 
inhibitor (chaetocin, a nonspecific histone methyltransferase 
inhibitor), and a histone deacetylase inhibitor (trichostatin A). 
IOX1 could suppress radiation- or coculture-induced CXCL12 
expression (Fig. 7A), and the other epigenetic inhibitors had 
little effect or enhanced the radiation-induced CXCL12 tran-
scription in the coculture and 3D tumor microenvironments 
(Supplementary Fig. S6).
Fig. 5. Continued.
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 Based on the IOX1 activity for the suppression of radi-
ation-induced CXCL12 in tumor microenvironment (Fig. 
7A), we also examined whether IOX1 could ameliorate the 
subpopulation of CSC marker-expressing cancer cells after 
radiation. IOX1 pretreatment reduced the subpopulation of 
CSC cells in Huh7 cells surviving radiation in the single-culture 
and coculture tumor microenvironment (Fig. 7B). Together 
with CXCL12’s transcription repression effect of IOX1 (Fig. 
7A), these results suggested that epigenetic inhibitors such 
as IOX1 can attenuate and control the adverse effects of ra-
diation in surviving cancer cells after radiotherapy and inhibit 
CXCL12 gene expression by modulating histone modifica-
tions to promote the effectiveness of radiation treatment by 
eliminating malignant cancer cells. Concurrently, correlated 
expression of the CSC marker, CD133 at the RNA level was 
also affected by the inhibitors (Fig. 7C).
 We also examined whether IOX1 could attenuate the radi-
ation-induced H3K4me3 and decrease H3K9me3 at CXCL12 
promoter leading to enhanced CXCL12 expression. IOX1 
could efficiently reverse radiation-induced H3K4me3, but 
it did not decrease H3K9me3 modifications at the CXCL12 
promoter (Fig. 7D). This suggested that IOX1 may exert its al-
leviating effects on radiation-induced CXCL12 expression by 
reversing H3K4me3 modification at the CXCL12 promoter.
 Because IOX1 could suppress the radiation-induced 
CXCL12 (Fig. 7A), we asked whether IOX1 could also re-
verse radiation-enhanced MMP2/9 expression (Fig. 7E) and 
invasion (Fig. 7F). IOX1 cotreatment with radiation abrogat-
ed the upregulation of MMP2/9 induced by radiation and 
attenuated radiation-enhanced invasiveness (Figs. 7E and 
7F). Remarkably, CXCL12 knockdown abrogated the IR-in-
duced MMP2/9 upregulation (Fig. 7E) and invasion (Figs. 4E 
and 7F), supporting the conclusion that radiation-induced 
CXCL12 plays an important role in the malignancy of IR-treat-
ed cancer cells.
DISCUSSION
Besides chemotherapy and surgery, approximately half of 
cancer patients undergo radiation therapy to decrease the 
bulk tumor mass and inhibit the spread of cancer cells. How-
ever, due to tumor heterogeneity depending on genetic, epi-
Fig. 6. Radiation or coculture increased the Huh7 cell subpopulation expressing stem cell markers (CD133+/CD24–). (A) A 
representative flow cytometry analysis of the Huh7 cell subpopulation expressing CD133+ CD24–. (B) 3D culture Huh7 cells were analyzed 
using flow cytometry for a subpopulation expressing CD133+ CD24–. Three days after irradiation or not (control), Huh7 cells were 
immunostained with CD133-FITC and CD24-PE and analyzed. All analyses were performed in three independent experiments. *P < 0.05, 
**P < 0.01, ***P < 0.001.
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genetic, phenotypic, and environmental differences, it is hard 
to accurately predict treatment responses. The interaction of 
cancer cells with their microenvironment is known to induce 
the consistent occurrence of tumor heterogeneity (Lee et 
al., 2016), which occasionally leads to the generation and 
maintenance of therapy resistance and tumor relapse (Junt-
tila and Sauvage, 2013). Radiotherapy interrupts cancer cells 
and has systemic effects on the tumor microenvironment by 
modifying the microenvironment (Lumniczky and Sáfrány, 
2015) and a complex biological network comprising the ex-
tracellular matrix and various cell types, including endothelial 
cells, fibroblasts, and immune cells (Kuonen et al., 2012) that 
can modify radiotherapy responsiveness. Changes within the 
irradiated tumor can include hypoxia formation and adap-
tation, angiogenesis, and enhanced metastasis (Imaizumi et 
al., 2010). These vicious processes involve signaling pathways 
such as CXCL12-CXCR4, cKit, SCF, MAP kinase signaling, 
and integrin signaling (Eke and Cordes, 2011; Imaizumi et 
al., 2010; Kong et al., 2014; Kryczek et al., 2007; Kuonen et 
al., 2012; Lagadec et al., 2012; Würth et al., 2014). Howev-
er, underlying mechanisms in which radiation induces these 
microenvironmental modifications (Eke and Cordes, 2011; 
Lagadec et al., 2012), resulting in modulation of therapy 
responsiveness and tumor progression, remain unclear. The 
question regarding the epigenetic effects of radiation on mi-
croenvironmental modifications warrants investigation.
 Here, we provide new evidence that radiation induces epi-
genetic modifications to the promoter of the CXCL12 gene in 
hepatoma cells, resulting in higher expression and activation 
of its downstream pathway, CXCL12-CXCR4/7. Additional-
ly, radiation was also shown to induce CXCR4 expression, 
a receptor for the CXCL12 ligand in surviving cancer cells, 
compared to non-irradiated cancer cells or purely cultured 
cancer cells. These findings are consistent with previous 
studies showing that ionizing radiation induces inflammato-
ry, growth factor, and cytokine signaling pathways like the 
CXCL12-CXCR4 axis (Haubner et al., 2012; Lee et al., 2016). 
Furthermore, our data show that epigenetic inhibitors mim-
icking or reversing radiation-induced modifications at the 
CXCL12 promoter synergize or abrogate radiation-induced 
CXCL12 expression, indicating that radiation-induced epi-
genetic modifications are critical molecular mechanisms for 
radiation effects in the tumor microenvironment.
 Previous work shows that radioresistant cancer subline 
cells exhibit higher CXCR4 expression compared to isogenic 
radiation-sensitive sublines (Haubner et al., 2012). Also, re-
Fig. 7. Modulation of CXCL12 expression and CSC marker by inhibitors of histone modifying enzymes (IOX1, GSK-J1, and TSA). (A) 
Huh-7 cells were cultured with (cocultured) or without IMR90 cells and pre treated with IOX-1 inhibitor for 24 h followed by IR exposure. 
The CXCL12 mRNA level of the unpretreated and unirradiated sample was arbitrarily set to one and compared to treated samples. (B and 
C) Expression of CD133+ CSC marker was also affected by inhibitors after treatment with IR. (D-F) Huh-7 cells were pretreated with IOX-
1 inhibitor for 24 h before irradiation. (D) In 3 days, modifications of H3K4me3 and H3K9me3 at the human CXCL12 promoter were 
evaluated. (E) MMP2 and MMP9 mRNA were measured. *P < 0.05, **P < 0.01, ***P < 0.001. (F) Invasion was evaluated by incubating 
Huh7 cells in a Matrigel-coated chamber. Scale bar = 100 mm.
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cent findings showed that the CXCL12-CXCR4/7 pathway is 
highly activated in CSCs originating from breast, lung, and 
prostate cancers (Dubrovska et al., 2012; Jung et al., 2013). 
These previous studies clearly describe correlation between 
CXCL12 signaling, cancer malignancy, and resistance/relapse. 
Targeting and eliminating CSC is difficult with standard ra-
diotherapy regimens because they are strongly resistant to 
radiation and adapt to the tumor microenvironment. This 
radioresistance mechanism can partially explain our experi-
mental data showing the CXCL12-CXCR4/7 upregulation by 
irradiation is due to expression changes induced by irradiation 
and the enrichment for radioresistant cells expressing higher 
CXCL12-CXCR4/7. Here, we analyzed the surviving residual 
cancer cells after radiation treatment for radiation-induced 
genes and their epigenetic signatures. Thus, our results to-
gether with recent reports on the role of the CXCL12-CXCR4 
pathway in the modulation of responsiveness to irradiation, 
resistance, and tumor relapse (Krause et al., 2011; Trautmann 
et al., 2014; Würth et al., 2014) propose that this axis plays 
an important role in generating and maintaining resistance in 
residual cancer cells after radiotherapy, leading to resistance, 
spreading, recurrence, and metastasis.
 There is an urgent need to identify the molecular mecha-
nisms regulating responsiveness to radiotherapy that are de-
veloped during therapy, in addition to preexisting resistance 
mechanisms before therapy. Taking into account the involve-
ment of the CXCL12-CXCR4 axis in resistant CSC (Dubrovska 
et al., 2012; Jung et al., 2013; Krause et al., 2011; Lagadec 
et al., 2012) and higher expression of CXCR4 in radioresis-
tant cancer subpopulations (Trautmann et al., 2014), our 
experimental data showing CXCL12-CXCR4 induction by 
radiation and its epigenetic molecular mechanisms show that 
irradiation kills bulk cancer cells and also generates resistant 
and more aggressive phenotypes in a small minority of cancer 
cells via epigenetic modulations. If this is the case, adoption 
of epigenetic inhibitors reversing radiation-induced epigen-
etic effects in combination with radiotherapy is needed to 
improve patient outcomes. Moreover, epigenetic anticancer 
strategies in combination with current therapy can target 
other mechanisms and pathways supporting resistance, 
relapse, metastasis, and cancer-favorable environmental fac-
tors, in addition to CXCL12-CXCR4/7 axis, by reprogramming 
gene expression alterations toward a normal state by revers-
ing epigenetic abnormalities in cancer cells. Surprisingly, bulk 
gene expression associated with carcinogenesis, malignancy, 
and resistance result from epigenetic and genetic alterations. 
Accordingly, many agents targeting cancer epigenetic abnor-
malities are under development and in clinical trials. The key 
potential for epigenetic therapies relies on the fact that epi-
genetic changes are reversible, allowing for recovery of the 
expression of epigenetically affected genes to their normal 
levels (Ahuja et al., 2014). An inhibitor of histone demeth-
ylase, IOX1, can also reverse expression of specific genes to 
a more normal state via changes int he histone modification 
pattern (Dobrynin et al., 2017; Hu et al., 2015). IOX1 can 
suppress cyclin D1 expression (Hu et al., 2015), and it can 
also lead to a decrease in Hif1α expression (Dobrynin et al., 
2017). Consistent with this, we found that the epigenetic 
inhibitor IOX1 can reverse radiation-induced H3K4me3 at 
the CXCL12 promoter, which is causally related to the atten-
Fig. 7. Continued.
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uation of CXCL12 expression. Due to the fact that CXCL12/
CXCR4 is involved in radiation-resistance (Trautmann et al., 
2014) and cancer stemness (Domanska et al., 2013; Kuonen 
et al., 2012) and our findings show that the epigenetic inhib-
itor IOX1 with radiation can block invasion and enrichment 
of cells expressing CSC marker (CD133+/CD24
–
), additional 
studies are needed to evaluate the potential therapeutic use 
of epigenetic targeting reagents in combination with radio-
therapy.
 In conclusion, we have shown that radiation modifies 
the expression of genes in the CXCL12-CXCR4 axis and 
epigenetic state of the CXCL12 promoter in tumor microen-
vironment, indicating a molecular mechanistic link between 
gene expression and epigenetic modifications in response 
to radiation. Our studies also suggest that radiation induces 
a change in the expression of CSC markers, resulting in an 
increase of the CSC-like subpopulation expressing CD133+/
CD24
– after radiation. Intriguingly, histone demethylase inhib-
itors or antagonists of the CXCL12-CXCR4 axis can reverse 
these radiation-induced effects, supporting the conclusion 
some poor radiation effects occur in an epigenetic modifica-
tion-dependent manner. Thus, it seems that the therapeutic 
inhibition of the CXCL12 signaling pathway via an epigenetic 
(histone demethylase inhibitor) or direct (antagonist of CX-
CL12-CXCR4/7) strategy is a promising therapeutic option to 
refine radiotherapy.
Note: Supplementary information is available on the Mole-
cules and Cells website (www.molcells.org).
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